🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Delighted to have the opportunity to present our data IASLC #WCLC22 on the frequency and detectability of uncommon EGFR mutations. PCR methods may miss 30% of cases. Suzanne MacMahon Wanda (Wanyuan) Cui Mary O'Brien Sanjay Popat

Also check out our E-poster describing the clinical outcomes of pts with uncommon EGFR mutations that received SACT. ORR of 47% in those that received 1L TKIs. We need to find these pts so we can treat with targeted therapy. IASLC #WCLC22

🎥 Wanda (Wanyuan) Cui of Peter Mac Cancer Centre talks on improving target identification in patients with advanced NSCLC via up-front ctDNA Watch: 👉ow.ly/4TpC50KiyFX👈 IASLC #WCLC22 #LCSM #LungCancer

Immunotherapies are revolutionising cancer treatment.. but they raced into the clinic with some oversights of possible side effects. Our new data alerts women & clinicians to potential risks to fertility & highlights the need to prioritise human studies nature.com/articles/s4301…

So exciting to see this new work published on immunotherapy impacts to fertility Nature Cancer. This research strongly advocates we must include reproductive endpoints in clinical trials moving forward! nature.com/articles/s4301…

An important study showing ICI causes ovarian tox in mice ❗️antiPDL1 & antiCTLA4 depleted primordial follicles by 50% & 46% ❗️increase in atretic secondary & antral follicles We need to assess ovarian tox in trials! Hutt Lab Karla Hutt amy winship Sherene Loi, MD Prof Kelly-Anne Phillips

Will be joining #teamTOGA to raise money for lung cancer research Help me catch up to Rachel Wong impressive fundraising effort using the link below 👇🏻 …oup-of-australasia-ltd.grassrootz.com/melbourne-mara…

Can targeted anti #cancer therapies (vs traditional #chemotherapy) still cause #ovarian toxicity and #infertility ? Find out Reproduction and Fertility (#OpenAccess) in this article by Roseanne Rosario, Wanda (Wanyuan) Cui & Richard A Anderson ➡️raf.bioscientifica.com/view/journals/… Andrew Horne norah spears

Join me at #COSA23 in November, talking about cancer treatment related ovarian toxicity cosaasm.org.au

New @asco recommendations on the need for collection of ovarian toxicity in cancer clinical trials !

🚨 New ASCO recommendations published in The Lancet Oncology. We need to better understand the impacts of cancer therapies on ovarian function so that patients have information about the risks to fertility and other longterm health implications from early menopause Prof Kelly-Anne Phillips

Incredible collaborative effort across regulatory agencies, industry, academic and community oncology to assess #ovariantoxicity in clinical trials Rod Rocconi Ramya Thota wanda @SuparnaWedam Matteo Lambertini, MD PhD #survivorship

So proud to be a part of these important recommendations. Goal is to improve the quality of life for many women with cancer #qol #ovariantoxicity

See here for the paper: thelancet.com/journals/lanon…

Knowing if a cancer treatment affects fertility or triggers early menopause is vital info for women and yet is rarely a focus of clinical trials. A new ASCO statement - by Wanda (Wanyuan) Cui, Prof Kelly-Anne Phillips and colleagues - aims to change this. More: petermac.org/about-us/news-…

Assessing ovarian toxicity in clinical trials is way overdue! 🪺 We’re so proud of these recommendations published in The Lancet Oncology Check them out here 👉🏼 thelancet.com/journals/lanon…

Thanks, Wanda (Wanyuan) Cui, Prof Kelly-Anne Phillips, Rod Rocconi, & Julie Gralow, for your leadership. Generating evidence to understand impacts of cancer therapies on ovarian function is crucial! ASCO doi.org/10.1016/S1470-…

Delighted to see this really important step forward in the care of women with cancer: ovarian toxicity assessment must be standard in oncology trials. Great work from ASCO led by @cuiwanda and Kelly-Anne Philips

Read the latest research from the Christie lab Peter Mac Research on MHCII and whole genome duplication in ovarian cancer, published with Springer Nature in Nature Communications nature.com/articles/s4146…